Akanda (AKAN) Enterprise Value (2020 - 2025)
Akanda's (AKAN) quarterly Enterprise Value came in at -$503562.0 in Q4 2025, up 86.89% year-on-year from -$269439.0 in Q4 2024, and up 80.05% quarter-over-quarter from -$2.5 million in Q2 2025.
Akanda (AKAN) Enterprise Value (2020 - 2025) Analysis & Trends
Akanda's Enterprise Value history runs 6 years deep, the most recent figure standing at -$503562.0 for Q4 2025.
- On a quarterly basis, Enterprise Value rose 86.89% year-over-year to -$503562.0 in Q4 2025; TTM through Dec 2025 was -$503562.0, a 86.89% increase from a year earlier, with the FY2025 full-year figure at -$503562.0, up 86.89% from the prior year.
- Enterprise Value rose to -$503562.0 in Q4 2025 per AKAN's latest filing, from -$2.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$93875.0 in Q4 2023 and bottomed at -$6.0 million in Q2 2024.
- The 5-year median for Enterprise Value is -$2.5 million (2025), against an average of -$2.3 million.
- Across the five-year window, Enterprise Value sank 25784.11% in 2021 and jumped 86.89% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$3.5 million in 2021, then jumped by 85.14% to -$519494.0 in 2022, then soared by 81.93% to -$93875.0 in 2023, then sank by 3992.53% to -$3.8 million in 2024, then soared by 86.89% to -$503562.0 in 2025.
- Per Business Quant, the three latest AKAN Enterprise Value figures stand at -$503562.0 (Q4 2025), -$2.5 million (Q2 2025), and -$3.8 million (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | -503,562.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -503,562.00 |
| Jun 30, 2025 | -2.52 Mn |
| Dec 31, 2024 | -3.84 Mn |
| Jun 30, 2024 | -6.01 Mn |
| Dec 31, 2023 | -93,875.00 |
| Jun 30, 2023 | -713,338.00 |
| Dec 31, 2022 | -519,494.00 |
| Jun 30, 2022 | -3.13 Mn |
| Dec 31, 2021 | -3.50 Mn |
| Dec 31, 2020 | -13,504.00 |